Unicamp and Entourage Phytolab sign unprecedented research partnership on cannabis for medicinal use

Monday, February 3, 2020 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Research will identify and analyse pharmacological, agricultural and genetic characteristics of 240 cannabis varieties for therapeutic purposes, such as refractory epilepsy

SÃO PAULO, Feb. 3, 2020 /PRNewswire/ -- The State University of Campinas (Unicamp) and Entourage Phytolab have just announced an agreement for the development of research on cannabis varieties for medicinal use. This is the second agreement to be negotiated by Inova Innovation Agency Unicamp with the company that focuses on the therapeutic purposes of cannabis.


The research project is called "Genotype Selection of Cannabis sativa L. for the Production of Medicines" and will be carried out over a 28-month period in conjunction with the Pluridisciplinary Center for Biological and Agricultural Chemical Research (CPQBA) of Unicamp, one of Latin America's top universities in science productivity.

"The aim is to describe the medicinal, productive and genetic characteristics of 240 cannabis varieties, which will be cultivated in controlled growth chambers, called phytotrons," explains Ílio Montanari Jr., project coordinator and curator of the CPQBA Unicamp medicinal plants collection.

"People tend to think that all cannabis plants are the same, but the truth is there are many different varieties. Research allows us to select the most resistant, productive and appropriate for each treatment, which leads to the development of innovative drugs that are even safer, more effective and more accessible," says Caio Santos Abreu, CEO of Entourage Phytolab.

Newton Frateschi, executive director of Inova Unicamp, highlights that the second agreement with Entourage demonstrates the success of university-business interaction focused on health. "It is a clear case that research and development at the university can become a product of great impact on society".

The start of the research still depends on the approval of the National Health Surveillance Agency (Anvisa) for the controlled cultivation of the plant varieties and only for research purposes. The plants will be grown exclusively within three phytotrons, which control temperature, air humidity, photoperiod and light intensity.

To safeguard the security of the research samples, the cultivation site will be monitored 24 hours a day by a security system implemented in the CPQBA by Entourage Phytolab, as foreseen in the agreement, which includes a rigid access control with biometric identification, double doors and cameras with remote monitoring.

Entourage is responsible for the costs of the project, which includes the identification and acquisition of the seeds, as well as the refurbishing and acquisition of the equipment, which will take place only after Unicamp obtains the Teaching and Research Establishment Authorization (AEP) for the project from Anvisa.

Cision View original content:http://www.prnewswire.com/news-releases/unicamp-and-entourage-phytolab-sign-unprecedented-research-partnership-on-cannabis-for-medicinal-use-300997746.html

SOURCE Entourage Phytolab



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store